Daily FNArena News - Australia

FNArena’s weekly update on short positions in the Australian share market.

Brokers are trawling portfolios to find the best placed oil stocks as the price of crude is expected to remain under pressure for some time yet.

FNArena provides a weekly update of Australian listed corporate bond issues, current pricing and yield data.

Gross gambling revenue may have slumped in Macau but brokers believe the Melco JV is a substantial player and Crown Resorts offers domestic upside.

The outlook for Australia’s gold miners is mixed, with attention centred on high quality, long life assets.

Despite falling commodity prices, Rio Tinto considers its pledge to increase shareholder returns as sacrosanct, although something has to give elsewhere.

With the transformation plan moving at a glacial pace brokers have pushed Metcash’s recovery further into the future.

The Commonwealth Department of Social Security has reversed a favourable tax treatment for Challenger Financial’s aged care annuities Brokers review the implications.

Weekly update on recommendation, target price, and earnings forecast changes.

Baillieu Holst is enthusiastic about Mesoblast’s plans to launch stem cell therapy for GvHD in 2016 and believes upside potential for the stock is substantial.